跳至主要内容
临床试验/CTRI/2024/11/076506
CTRI/2024/11/076506尚未招募不适用

The objective of this study will be to evaluate the irritation potential on healthy human subjects having Varied skin types of skin & hair care formulations

Kama Ayurveda Pvt Ltd.1 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2024年11月16日

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
26
试验地点
1
主要终点
Dermatological safety / Irritation potential on skin

研究概览

简要总结

Objective: The objective of this study will be to evaluate the irritation potential on healthy human subjects having Varied skin types of Skin & Hair Care Formulations

Duration of study: 8 days study

Kinetics: T0 (Evaluation of test sites by Dermatologist, Patch application) ,T1(Patch removal, Evaluation of test sites by Dermatologist ,T2(Evaluation of test sites by Dermatologist and Subject post 24 hrs of patch removal), T8 (Evaluation of test sites by Dermat and Subject post 1 week of patch removal and tracking the positive cases)

Population: 26 healthy subjects (13 males + 13 females) with varied skin types.

The test area is checked for erythema and oedema caused due to the products and compared with positive control

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Healthy Human Subjects 2) Skin should be healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….).
  • Subjects willing to come for regular follow up and ready to follow instructions during the study period.
  • Subjects representing varied skin types (ideally equal representation of all 4 skin types – Oily, Normal, Dry and Combination).

排除标准

  • 1 For female: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months 2 Having refused to give his/her assent by not signing the consent form 3 Taking part in another study liable to interfere with this study 4 Being diabetic.
  • 5 Being asthmatic.
  • 6 Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
  • 7 Having cutaneous hypersensitivity (except in the case of studies with evaluation of sensitive skin).
  • 8 Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
  • 9 Having undergone a surgery requiring a general anaesthesia of more than one hour in the past 6 months.
  • 10 Having changed his/her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit.

结局指标

主要结局

Dermatological safety / Irritation potential on skin

时间窗: Baseline,0 hrs,24 hrs and 7 days

次要结局

未报告次要终点

研究者

发起方
Kama Ayurveda Pvt Ltd.
申办方类型
Other [Fast-Moving Consumer Goods]
责任方
Principal Investigator
主要研究者

Dr Pooja Yadav

MASCOT-SPINCONTROL India Pvt. Ltd.

研究点 (1)

Loading locations...

相似试验